Humanoid Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	24.15	21.14	18.59	14.01	12.55
Revenue Growth	14.25%	13.71%	32.64%	11.68%	-98.66%
Cost of Revenue	16.07	14.1	13	10	9.31
Gross Profit	8.08	7.04	5.59	4.01	3.24
Selling, General & Admin	0.88	0.78	0.68	0.56	0.5
Operating Expenses	0.88	0.78	0.68	0.56	0.5
Operating Income	7.2	6.26	4.91	3.46	2.74
Interest Expense	-0.01	-0	-0	-0	-0
Other Non Operating Income (Expenses)	0.87	0.76	0.4	0.26	0.25
Pretax Income	8.07	7.02	5.31	3.72	2.99
Net Income	8.07	7.02	5.31	3.72	2.99
Net Income to Common	8.07	7.02	5.31	3.72	2.99
Net Income Growth	15.00%	32.21%	42.78%	24.27%	-97.33%
Shares Outstanding (Basic)	157	157	157	157	157
Shares Outstanding (Diluted)	157	157	157	157	157
Shares Change	-	-	-	-	-
EPS (Basic)	0.05	0.04	0.03	0.02	0.02
EPS (Diluted)	0.05	0.04	0.03	0.02	0.02
EPS Growth	15.00%	32.21%	42.78%	24.26%	-97.33%

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	2.74	2.72	0.4	1.94	-0.89
Free Cash Flow Per Share	0.02	0.02	0.00	0.01	-0.01
Gross Margin	33.46%	33.31%	30.06%	28.64%	25.82%
Operating Margin	29.81%	29.62%	26.41%	24.67%	21.84%
Profit Margin	33.41%	33.20%	28.55%	26.52%	23.84%
Free Cash Flow Margin	11.34%	12.87%	2.15%	13.84%	-7.08%
EBITDA	7.66	6.66	5.21	3.76	3.02
EBITDA Margin	31.72%	31.49%	28.02%	26.81%	24.05%
D&A For EBITDA	0.46	0.4	0.3	0.3	0.28
EBIT	7.2	6.26	4.91	3.46	2.74
EBIT Margin	29.81%	29.62%	26.41%	24.67%	21.84%